REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | – | 4 | -81.8% | 0.00% | – |
| Q1 2024 | $0 | – | 22 | +120.0% | 0.00% | – |
| Q4 2023 | $0 | – | 10 | -9.1% | 0.00% | – |
| Q3 2023 | $0 | – | 11 | -21.4% | 0.00% | – |
| Q2 2023 | $0 | – | 14 | +180.0% | 0.00% | – |
| Q1 2023 | $0 | – | 5 | -50.0% | 0.00% | – |
| Q4 2022 | $0 | – | 10 | +66.7% | 0.00% | – |
| Q3 2022 | $0 | – | 6 | -50.0% | 0.00% | – |
| Q2 2022 | $0 | – | 12 | +33.3% | 0.00% | – |
| Q1 2022 | $0 | – | 9 | -18.2% | 0.00% | – |
| Q4 2021 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
| Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
| ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
| Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
| Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
| RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
| WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
| HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
| Atom Investors LP | 36,487 | $901,000 | 0.39% |